Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
03/2001
03/08/2001WO2001016306A2 Chimeric antisense oligonucleotides and cell transfecting formulations thereof
03/08/2001WO2001016161A1 SYNTHESIS OF TEMPLATE-FIXED β-HAIRPIN LOOP MIMETICS
03/08/2001WO2001016152A2 Method for anchoring oligonucleotides to a substrate
03/08/2001WO2001016151A1 Reversible photocoupling nucleic acid and phosphoroamidite
03/08/2001WO2001016150A2 Nucleoside analogues
03/08/2001WO2001016149A2 2-azapurine compounds and their use
03/08/2001WO2001016090A1 Enantiomerically-enriched compounds having photocleavable bond(s) and methods related thereto
03/08/2001WO2001015800A1 Method and device for performing operations at charged microlocations
03/08/2001WO2001015739A1 Antisense modulation of human rho family gene expression
03/08/2001CA2403243A1 Nucleic acid based modulators of gene expression
03/08/2001CA2384191A1 Enantiomerically-enriched compounds having photocleavable bond(s) and methods related thereto
03/08/2001CA2382663A1 Uv excitable fluorescent energy transfer dyes
03/08/2001CA2382324A1 Nucleoside analogues
03/08/2001CA2382121A1 Methods of immobilizing ligands on solid supports and apparatus and methods of use therefor
03/08/2001CA2381761A1 Method for anchoring oligonucleotides to a substrate
03/07/2001EP1081163A1 Macromolecular arrays on polymeric brushes and methods for preparing the same
03/07/2001EP1080233A1 Compounds, screening methods, and uses involving anti-apoptotic genes and gene products
03/07/2001EP1080231A1 Multimolecular devices, drug delivery systems and single-molecule selection
03/07/2001EP1080226A1 Compositions and methods for topical delivery of oligonucleotides
03/07/2001EP1080192A2 Antisense oligonucleotides for treating proliferating cells
03/07/2001EP1080103A1 Compositions and methods for non-parenteral delivery of oligonucleotides
03/07/2001EP1080100A1 Cytosine deaminase gene
03/07/2001EP1080099A1 Method and device for purifying nucleic acids
03/07/2001EP1079920A1 Device and method for producing a system of chain molecules on a support material
03/07/2001EP0915935B1 4,7-dichlororhodamine dyes
03/07/2001CN1286691A Oligonucleotide synthesis using high boiling point solvents
03/07/2001CN1286259A Process for separating nucleotide from enzymolyzed ribonucleic acid liquid
03/07/2001CN1062908C Polypeptides and DNAs encoding them
03/06/2001US6197949 Supports and novel processes for binding oligonucleotides
03/06/2001US6197944 DNA molecules stabilized by modifications of the 3′-terminal phosphodiester linkage
03/06/2001US6197937 Antibody which preferentially binds mammalian binding protein; for the treatment of atherosclerosis
03/06/2001US6197925 NF-AT polypeptides and polynucleotides
03/06/2001US6197755 Compositions and methods for delivery of genetic material
03/06/2001US6197566 α-galactosidase enzyme
03/06/2001US6197563 Accumulation of nucleotide sequences; for diagnosis of infections and screening for nucleotide sequence polymorphisms
03/06/2001US6197555 Nucleotide compounds including a rigid linker
03/06/2001US6197521 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells
03/06/2001US6197514 Amplification and detection of Yersinia enterocolitica
03/06/2001US6197513 PNA and DNA conjugates and methods for preparation thereof
03/06/2001US6197506 Using substrate having over 100 different polynucleotides at density of over 50 different polynucleotides per square centimeter to generate hybridization patterns and distinguish between two nucleic acid samples; heredity; diagnosis
03/06/2001US6197310 Causative agent of the mystery swine disease, vaccine compositions and diagnostics kits
03/06/2001CA1341197C Gm-csf protein, its derivatives, the preparation of proteins of this type, and their use
03/01/2001WO2001014589A2 Liquid array technology
03/01/2001WO2001014585A1 Immobilising and marking biopolymers
03/01/2001WO2001014555A1 Human narcolepsy gene
03/01/2001WO2001014536A2 Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence
03/01/2001WO2001014417A2 Pesticidal proteins
03/01/2001WO2001014400A1 2'-o-acetamido modified monomers and oligomers
03/01/2001WO2000066607A8 Detection using degradation of a tagged sequence
03/01/2001WO2000048638A3 Multi-mutant diphtheria toxin vaccines
03/01/2001DE10016073A1 Covalent immobilization of biopolymers, useful for studying e.g. gene expression, by coupling amino group on biopolymer to reactive group on substrate
03/01/2001CA2344469A1 Pesticidal proteins
03/01/2001CA2317179A1 Macromolecular arrays on polymeric brushes and methods for preparing the same
02/2001
02/28/2001EP1078098A1 Method and probes for the detection of chromosome aberrations
02/28/2001EP1078079A1 Methods of forming protein-linked lipidic microparticles, and compositions thereof
02/28/2001EP1078053A2 METHODS FOR REGULATING HEMATOPOIESIS USING CpG-OLIGONUCLEOTIDES
02/28/2001EP1077999A2 Moraxella catharralis proteins
02/28/2001EP0851939A4 Methods for labeling dna ends with halogenated nucleotides and detecting same with antibodies
02/28/2001CN1285871A i (dull 1) coding for a starch synthase and uses thereof
02/28/2001CN1285514A Medicine box bof testing anti-hepatitis C virus antibody
02/27/2001US6194598 Aminooxy-modified oligonucleotide synthetic intermediates
02/27/2001US6194563 Solid phase nucleic acid labeling by transamination
02/27/2001US6194562 Endotoxin reduction in nucleic acid purification
02/27/2001US6194546 Influenza virus haemagglutinin which has a heterologous epitope at antigenic site a; vaccines against foot-and-mouth disease, poliovirus, human rhinovirus, hepatitis b virus, plasmodium and bacteria
02/27/2001US6194388 Immunomodulatory oligonucleotides
02/27/2001US6194187 Apoptosis-inducing protein and gene encoding the same
02/27/2001US6194162 Method of screening for compounds that bind P2x receptor
02/27/2001US6194150 Nucleic acid based inhibition of CD40
02/27/2001US6194149 Target-dependent reactions using structure-bridging oligonucleotides
02/27/2001US6194146 Situ and in vitro hybridization method and buffer
02/27/2001US6194142 Nucleotide sequences derived from the genome of retroviruses of the HIV-1, HIV-2, and SIV type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses
02/27/2001US6193965 Administering therapeutically effective amount of reagent which modulates kinase activity for treating cell proliferative disorder associated with c-jun n-terminal kinase disorder,
02/27/2001CA2025598C Chimaeric hepadnavirus core antigen proteins
02/22/2001WO2001012853A1 Method for identification of the indicators of contamination in samples
02/22/2001WO2001012835A1 Hiv-1 primers for uracil deglycosylase-based cloning
02/22/2001WO2001012813A1 Gene encoding merozoite protein of babesia caballi, recombinant protein obtained therefrom and utilization thereof
02/22/2001WO2001012804A2 MODULATION OF OLIGONUCLEOTIDE CpG-MEDIATED IMMUNE STIMULATION BY POSITIONAL MODIFICATION OF NUCLEOSIDES
02/22/2001DE19939578A1 New nucleic acid encoding hemocyanin, useful for gene therapy of tumors and for recombinant production of fusion proteins for vaccination
02/22/2001CA2784789A1 Modulation of oligonucleotide cpg-mediated immune stimulation by positional modification of nucleosides
02/22/2001CA2381993A1 Modulation of oligonucleotide cpg-mediated immune stimulation by positional modification of nucleosides
02/21/2001EP1077264A2 DNA chip, PNA chip, and their preparation methods
02/21/2001EP1076720A2 NUCLEOTIDE SEQUENCES FOR DETECTING ENTEROHEMORRHAGIC $i(ESCHERICHIA COLI) (EHEC)
02/21/2001EP0784683B1 Tie-2 ligands, methods of making and uses thereof
02/20/2001US6191278 Water-soluble rhodamine dyes and conjugates thereof
02/20/2001US6191268 Nucleotide sequence coding human maintenance protein; for the detection and treatment of tumors; for the detection of oncogenes
02/20/2001US6191266 Sugar modified nucleosides
02/20/2001US6191261 Immunoglobulin that preferential binds a growth factor; for the diagnosis and treatment of cell proliferative defects; antiproliferative agents
02/20/2001US6190869 Antisense inhibition of protein kinase C-theta expression
02/20/2001CA2197233C Methods of identifying compounds useful for treating autoimmune diseases
02/20/2001CA2033730C Heparin-binding growth factor
02/15/2001WO2001011010A2 Drug target isogenes: polymorphisms in the immunoglobulin e receptor i alpha subunit gene
02/15/2001WO2001010908A1 Ntr3, a member of the tnf-receptor supergene family
02/15/2001WO2000069872A3 pH DEPENDENT ION EXCHANGE MATRIX AND METHOD OF USE IN THE ISOLATION OF NUCLEIC ACIDS
02/15/2001WO2000049144A3 Pyk2 binding proteins
02/15/2001WO1999066079A9 Detection of non-viral organisms with srp rna
02/15/2001DE19905913C1 Stabilizing double-stranded nucleic acid, useful e.g. in restoring double strands after sterilization, by incubation with histone-like protein from Thermotoga maritima
02/14/2001EP1075544A1 Chemically modified nucleic acids and methods for coupling nucleic acids to solid support
02/14/2001EP1075543A2 Reduced complexity nucleic acid targets and methods of using same
02/14/2001EP0968226A4 G-rich oligo aptamers and methods of modulating an immune response
02/14/2001EP0708767B1 Haptens, tracers, immunogens and antibodies for carbazole and dibenzofuran derivatives